|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Expression of extradomain-Bcontaining fibronectin in subretinal choroidal neovascular membranes显示文摘 | Nicolà M Birò A Cardillo-Piccolino F | | 0，，： | 1 |
| 2 | E Sinn显示文摘 | Munno G De Julve M NicolòF | 1993 | Angew Chem Int Ed Engl1993，32，： | 1 |
| 3 | Ceramide inhibits antigen uptake and presentation by dendritic cells显示文摘 | Sallusto F NicolòC De Maria R | 1996 | J Exp Med1996，184，6： | 1 |
| 4 | Rapid and robust control of single quantum dots显示文摘The combination of single particle detection and ultrafast laser pulses is an instrumental method to track dynamics at the femtosecond time scale in single molecules,quantum dots and plasmonic nanoparticles.Optimal control of the extremely short-lived coherences of these individual systems has so far remained elusive,yet its successful implementation would enable arbitrary external manipulation of otherwise inaccessible nanoscale dynamics.In ensemble measurements,such control is often achieved by resorting to a closed-loop optimization strategy,where the spectral phase of a broadband laser field is iteratively optimized.This scheme needs long measurement times and strong signals to converge to the optimal solution.This requirement is in conflict with the nature of single emitters whose signals are weak and unstable.Here we demonstrate an effective closed-loop optimization strategy capable of addressing single quantum dots at room temperature,using as feedback observable the two-photon photoluminescence induced by a phase-controlled broadband femtosecond laser.Crucial to the optimization loop is the use of a deterministic and robust-against-noise search algorithm converging to the theoretically predicted solution in a reduced amount of steps,even when operating at the few-photon level.Full optimization of the single dot luminescence is obtained within~100 trials,with a typical integration time of 100 ms per trial.These times are faster than the typical photobleaching times in single molecules at room temperature.Our results show the suitability of the novel approach to perform closed-loop optimizations on single molecules,thus extending the available experimental toolbox to the active control of nanoscale coherences. | Nicolò Accanto Pablo M de Roque Marcial Galvan-Sosa Sotirios Christodoulou Iwan Moreels Niek F van Hulst | 2016 | Light(Science & Applications)2016，5，1： | 0 |
| 5 | Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients显示文摘AIM: To determine the clinical reasons for conversion to everolimus(EVL) and long-term outcomes in heart transplant(HT) recipients.METHODS: A retrospective 12-mo study has been carried out in 14 Spanish centres to assess the efficacy and safety of conversion to EVL in maintenance HT recipients.RESULTS: Two hundred and twenty-two patients were included(mean age: 53 ± 10.5 years; mean time from HT: 8.1 ± 4.5 years). The most common reasons for conversion were nephrotoxicity(30%), chronic allograft vasculopathy(20%) and neoplasms(17%). The doses and mean levels of EVL at baseline(conversion to EVL) and after one year were 1.3 ± 0.3 and 1.2 ± 0.6 mg/d and 6.4 ± 3.4 and 5.6 ± 2.5 ng/mL, respectively. The percentage of patients receiving calcineurin inhibitors(CNIs) at baseline and on the final visit was 95% and 65%, respectively. The doses and mean levels of CNIs decreased between baseline and month 12 from 142.2 ± 51.6 to 98.0 ± 39.4 mg/d(P < 0.001) and from 126.1 ± 50.9 to 89.2 ± 47.7 ng/mL(P < 0.001), respectively, for cyclosporine, and from 2.9 ± 1.8 to 2.6 ± 1.9 mg/d and from 8.3 ± 4.0 to 6.5 ± 2.7 ng/mL(P = 0.011) for tacrolimus. In the subgroup of patients converted because of nephrotoxicity, creatinine clearance increased from 34.9 ± 10.1 to 40.4 ± 14.4 mL/min(P < 0.001). There were 37 episodes of acute rejection in 24 patients(11%). The most frequent adverse events were oedemas(12%), infections(9%) and gastrointestinal problems(6%). EVL was suspended in 44 patients(20%). Since the database was closed at the end of the study, no further followup data is available.CONCLUSION: Conversion to EVL in maintenance HT recipients allowed minimisation or suspension of the CNIs, with improved kidney function in the patients with nephrotoxicity, after 12 mo. | Nicolás Manito Juan F Delgado María G Crespo-Leiro José María Arizón Javier Segovia Francisco González-Vílchez Sònia Mirabet Ernesto Lage Domingo Pascual-Figal Beatriz Díaz Jesús Palomo Gregorio Rábago Marisa Sanz Teresa Blasco Eulàlia Roig | 2015 | World Journal of Transplantation2015，5，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员